9-valent, quadrivalent HPV vaccines have comparable safety

The 9-valent human papillomavirus vaccine was well tolerated in 16-26 year olds and had a safety profile comparable to that of the quadrivalent vaccine, according to an analysis of seven phase III...
Source: Pediatric News - Category: Journals (General) Source Type: news